We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aggressive 'Culture of Approval' Harms FDA Drug Review Process, Witnesses Say
Aggressive 'Culture of Approval' Harms FDA Drug Review Process, Witnesses Say
February 16, 2007
A forceful “culture of approval” and attempts to muffle scientific dissent among agency reviewers have created significant problems in the FDA’s drug review process, witnesses at a House subcommittee hearing testified.